Workflow
Lumentum(LITE) - 2025 Q4 - Annual Results
2025-08-12 20:17
NEWS RELEASE LUMENTUM ANNOUNCES FOURTH QUARTER AND FULL FISCAL YEAR 2025 RESULTS Fiscal Fourth Quarter Highlights: Fiscal Year 2025 Highlights: San Jose, Calif., August 12, 2025 – Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fourth quarter and full fiscal year ended June 28, 2025. "In our fiscal fourth quarter, we executed exceptionally well in meeting robust demand across our portfolio of cloud products supporting AI data centers," said Michael Hurlston, Lumentum Pres ...
GCT Semiconductor Holding, Inc.(GCTS) - 2025 Q2 - Quarterly Results
2025-08-12 20:16
[Company Announcement & Overview](index=1&type=section&id=Company%20Announcement%20%26%20Overview) [Introduction & Key Highlights](index=1&type=section&id=Introduction%20%26%20Key%20Highlights) GCT Semiconductor announced Q2 2025 results, highlighting 5G chipset sample deliveries and an $11 million offering for 5G development - GCT Semiconductor has delivered initial **5G chipset samples** to key customers and is preparing for mass production and volume shipments in the second half of fiscal year 2025[1](index=1&type=chunk)[3](index=3&type=chunk) - The company completed an **$11 million** registered direct offering, with proceeds allocated for 5G chipset sampling and debt repayment[3](index=3&type=chunk)[5](index=5&type=chunk) [Second Quarter 2025 Financial Snapshot](index=1&type=section&id=Second%20Quarter%202025%20Financial%20Snapshot) GCT Semiconductor's Q2 2025 saw a year-over-year decline in net revenue and a significant drop in gross margin Second Quarter 2025 Financial Snapshot | Metric | Q2 2025 (Millions USD) | Q2 2024 (Millions USD) | Change (%) | | :----- | :--------------------- | :--------------------- | :--------- | | Net Revenue | $1.2 | $1.5 | -19.0% | | Gross Margin | 32.0% | 62.7% | -30.7 percentage points | [Business Developments & Strategy](index=1&type=section&id=Business%20Developments%20%26%20Strategy) [2025GCT – Year of 5G Program Update and other Highlights](index=1&type=section&id=2025GCT%20%E2%80%93%20Year%20of%205G%20Program%20Update%20and%20other%20Highlights) GCT's 'Year of 5G' program advances with 5G chipset evaluations, sample deliveries, and supply chain coordination - Successfully completed initial **5G chipset evaluations** and initiated supply chain coordination for mass production[5](index=5&type=chunk) - Delivered initial **5G chipset samples** to key customers, including Orbic North America and Airspan Networks, with more samples to follow for initial demand[5](index=5&type=chunk) [Strategic Collaborations & Capital Activities](index=1&type=section&id=Strategic%20Collaborations%20%26%20Capital%20Activities) GCT expanded market reach through Iridium and Giesecke+Devrient partnerships, raising $11 million for 5G and debt - Partnered with Iridium Communications Inc. to integrate **Iridium NTN Direct℠ services** into GCT's GDM7243SL chipset, expanding into the non-terrestrial market[5](index=5&type=chunk) - Collaborated with Giesecke+Devrient to launch innovative **eSIM solutions** for IoT devices[5](index=5&type=chunk) - Completed an **$11 million** registered direct offering, with net proceeds partially used for 5G chipset sampling and debt repayment[5](index=5&type=chunk) [Financial Performance & Position](index=2&type=section&id=Financial%20Performance%20%26%20Position) [Detailed Second Quarter 2025 Financial Results](index=5&type=section&id=Detailed%20Second%20Quarter%202025%20Financial%20Results) GCT Semiconductor reported a **$13.5 million** net loss in Q2 2025, due to revenue decline, foreign exchange losses, and higher interest expense Consolidated Statements of Operations (Three Months Ended June 30, Thousands USD) | Metric | Q2 2025 | Q2 2024 | YoY Change | | :-------------------- | :------ | :------ | :--------- | | Total Net Revenue | $1,182 | $1,468 | -19.5% | | Product Revenue | $408 | $18 | +2166.7% | | Service Revenue | $774 | $1,450 | -46.6% | | Gross Profit | $378 | $921 | -59.0% | | Total Operating Expenses | $7,970 | $8,000 | -0.4% | | Operating (Loss) | $(7,592) | $(7,079) | -7.2% | | Interest Expense | $(1,532) | $(760) | +101.6% | | Foreign Exchange Transaction (Loss) Net | $(3,217) | $816 | N/A (from gain to loss) | | Net Loss | $(13,538) | $(1,043) | +1197.9% | | Basic and Diluted Loss Per Share | $(0.26) | $(0.02) | +1200.0% | [Liquidity and Capital Resources](index=2&type=section&id=Liquidity) GCT's June 30, 2025 liquidity included cash, receivables, and inventory, supplemented by ATM offering and S-3 registration capacity Liquidity Position (As of June 30, 2025) | Asset Category | Amount (Millions USD) | | :------------- | :-------------------- | | Cash and Cash Equivalents | $1.3 | | Net Accounts Receivable | $3.8 | | Inventory | $3.0 | - The company has access to an effective **ATM offering program of up to $75 million** and approximately **$114 million** remaining under its **$200 million S-3 registration statement**[6](index=6&type=chunk) [Outlook & Corporate Information](index=2&type=section&id=Outlook%20%26%20Corporate%20Information) [5G Outlook](index=2&type=section&id=5G%20Outlook) GCT Semiconductor expects to begin production of initial 5G chipsets in Q3 2025, with mass shipments planned for Q4 2025 - Production of finalized initial **5G chipsets** is anticipated to commence in Q3 2025[7](index=7&type=chunk) - Mass shipments of **5G chipsets** are projected to begin in Q4 2025[7](index=7&type=chunk) [About GCT Semiconductor Holding, Inc.](index=2&type=section&id=About%20GCT%20Semiconductor%20Holding%2C%20Inc.) GCT Semiconductor is a leading fabless designer and supplier of advanced 5G and 4G LTE semiconductor solutions for commercial devices - GCT is a leading fabless designer and supplier of advanced **5G and 4G LTE semiconductor solutions**[10](index=10&type=chunk) - Its system-on-chip solutions integrate RF, baseband modem, and digital signal processing functions, offering complete **4G and 5G platform solutions**[10](index=10&type=chunk) [Conference Call & Investor Relations](index=2&type=section&id=Conference%20Call) GCT Semiconductor will host an August 12, 2025 conference call and webcast to discuss business and financial results, with investor contacts provided - A conference call and webcast are scheduled for **Tuesday, August 12, 2025, at 4:30 PM ET**, to discuss business updates and financial results[8](index=8&type=chunk) - Investor Relations contact: Gateway Group, Ralf Esper, GCT@gateway-grp.com. Media contact: media@gctsemi.com[14](index=14&type=chunk) [Cautionary Statement Regarding Forward-Looking Statements](index=2&type=section&id=Cautionary%20Statement%20Regarding%20Forward-Looking%20Statements) This section cautions on forward-looking statements, highlighting inherent risks and uncertainties that may cause actual results to differ - Forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from expected outcomes[13](index=13&type=chunk) - Factors include the company's ability to develop 5G products, fulfill partnership obligations, manage growth, raise sufficient capital, and meet market demand[13](index=13&type=chunk) [Consolidated Financial Statements](index=4&type=section&id=Consolidated%20Financial%20Statements) [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) Consolidated balance sheets show a decrease in total assets and an increase in total liabilities from December 2024 to June 2025 Consolidated Balance Sheet Highlights (Thousands USD) | Metric | June 30, 2025 | December 31, 2024 | Change | | :-------------------------- | :------------ | :---------------- | :----- | | Total Assets | $17,619 | $19,897 | $(2,278) | | Total Liabilities | $87,595 | $79,212 | $8,383 | | Total Stockholders' Deficit | $(69,976) | $(59,315) | $(10,661) | | Current Assets | $15,746 | $17,591 | $(1,845) | | Current Liabilities | $74,044 | $60,922 | $13,122 | [Consolidated Statements of Operations](index=5&type=section&id=Consolidated%20Statements%20of%20Operations) Consolidated statements of operations show a significant increase in net loss for both periods, driven by revenue decline and increased expenses Consolidated Statements of Operations (Six Months Ended June 30, Thousands USD) | Metric | 2025 | 2024 | YoY Change | | :-------------------- | :----- | :----- | :--------- | | Total Net Revenue | $1,678 | $4,733 | -64.6% | | Product Revenue | $499 | $2,396 | -79.2% | | Service Revenue | $1,179 | $2,337 | -49.6% | | Gross Profit | $466 | $2,874 | -83.8% | | Total Operating Expenses | $15,798 | $2,717 | +481.5% | | Operating (Loss) | $(15,332) | $157 | N/A (from gain to loss) | | Net Loss | $(20,506) | $(286) | +7069.9% | | Basic and Diluted Loss Per Share | $(0.41) | $(0.01) | +4000.0% |
cord Acquisition III(CNDB) - 2025 Q2 - Quarterly Results
2025-08-12 20:16
GCT Semiconductor Holding, Inc. Provides Business Update and Reports Second Quarter 2025 Financial Results Company delivered initial 5G chipset samples to lead customers, in preparation for mass production and volume shipments in the second half of fiscal 2025 SAN JOSE, CA – August 12, 2025 – GCT Semiconductor Holding, Inc. ("GCT" or the "Company") (NYSE: GCTS), a leading designer and supplier of advanced 5G and 4G semiconductor solutions, today provided an update on business developments and reported finan ...
Annovis Bio(ANVS) - 2025 Q2 - Quarterly Results
2025-08-12 20:16
Exhibit 99.1 Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results Malvern, Pa., August 12, 2025 – Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today provided corporate updates and second quarter 2025 financial results. "In the past quarter, our efforts were centered on driving enrollment f ...
Willamette Valley Vineyards, Inc.(WVVIP) - 2025 Q2 - Quarterly Report
2025-08-12 20:16
UNITED STATES Oregon 93-0981021 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 8800 Enchanted Way, S.E., Turner, Oregon 97392 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (503) 588-9463 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 o TRANSITIO ...
Dune Acquisition (DUNE) - 2025 Q2 - Quarterly Report
2025-08-12 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-39819 GLOBAL GAS CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-1617911 (IRS ...
Global Gas(HGAS) - 2025 Q2 - Quarterly Report
2025-08-12 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-39819 GLOBAL GAS CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-1617911 (IRS ...
Willamette Valley Vineyards(WVVI) - 2025 Q2 - Quarterly Report
2025-08-12 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT Commission File Number 001-37610 WILLAMETTE VALLEY VINEYARDS, INC. (Exact name of registrant as specified in charter) Oregon 93-0981021 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identificatio ...
BioRestorative Therapies(BRTX) - 2025 Q2 - Quarterly Results
2025-08-12 20:16
[Form 8-K Current Report](index=1&type=section&id=Form%208-K%20Current%20Report) [Item 2.02: Result of Operations and Financial Condition](index=2&type=section&id=Item%202.02.%20Result%20of%20Operations%20and%20Financial%20Condition.) BioRestorative Therapies, Inc. announced Q2 2025 financial results via a press release on August 12, 2025, which is furnished, not filed, under the Securities Exchange Act - The company announced its financial results for the second quarter ended June 30, 2025, through a press release issued on August 12, 2025[3](index=3&type=chunk) - The press release, furnished as Exhibit 99.1, also contained a business update and information regarding a conference call to discuss the results[3](index=3&type=chunk) - The information furnished under this item, including Exhibit 99.1, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless explicitly stated[5](index=5&type=chunk) [Item 7.01: Regulation FD Disclosure](index=2&type=section&id=Item%207.01%20Regulation%20FD%20Disclosure.) This section clarifies that the press release information is furnished under Regulation FD, not filed, and is not automatically incorporated by reference or deemed material - The information provided in the press release is being furnished, not filed, and will not be incorporated by reference into any registration statement unless specifically identified[6](index=6&type=chunk) - The company states that furnishing the information does not mean it is material, complete, or necessary for an investment decision[6](index=6&type=chunk) [Item 9.01: Financial Statements and Exhibits](index=2&type=section&id=Item%209.01%20Financial%20Statements%20and%20Exhibits.) This section lists the exhibits filed with the Form 8-K, including the Q2 2025 financial results press release and the interactive data file Exhibits Filed | Exhibit Number | Description | | :--- | :--- | | 99.1 | Press release, dated August 12, 2025, issued by BioRestorative Therapies, Inc. | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | [Signatures](index=3&type=section&id=SIGNATURES) The report was officially signed and authorized by Robert Kristal, Chief Financial Officer of BioRestorative Therapies, Inc., on August 12, 2025 - The report was signed on behalf of the company by Robert Kristal, Chief Financial Officer[11](index=11&type=chunk) - Date of signature: August 12, 2025[11](index=11&type=chunk)
PSQ (PSQH) - 2025 Q2 - Quarterly Report
2025-08-12 20:16
[PART I—FINANCIAL INFORMATION](index=4&type=section&id=PART%20I%E2%80%94FINANCIAL%20INFORMATION) This part presents the interim condensed consolidated financial statements and management's discussion and analysis for the period ended June 30, 2025 [Interim Condensed Consolidated Financial Statements](index=4&type=section&id=Item%201.%20Interim%20Condensed%20Consolidated%20Financial%20Statements) Unaudited interim financials for Q2 2025 show increased revenues, reduced net loss, and a strategic pivot to FinTech [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets decreased to **$65.5 million** by June 30, 2025, driven by reduced cash and equity Condensed Consolidated Balance Sheet Highlights (Unaudited) | Metric | June 30, 2025 ($) | December 31, 2024 ($) | | :--- | :--- | :--- | | Cash and cash equivalents | 20,577,116 | 36,324,354 | | Total current assets | 32,176,723 | 46,837,162 | | Total assets | 65,454,999 | 74,893,841 | | Total current liabilities | 10,851,602 | 8,624,419 | | Total liabilities | 43,003,606 | 48,043,635 | | Total stockholders' equity | 22,451,393 | 26,850,206 | [Condensed Consolidated Statements of Operations](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Q2 2025 revenues grew **18%** to **$7.1 million**, with net loss improving to **$8.4 million** Q2 Financial Performance (Three Months Ended June 30) | Metric | 2025 ($) | 2024 ($) | YoY Change | | :--- | :--- | :--- | :--- | | Revenues, net | 7,082,868 | 5,985,228 | +18.3% | | Operating loss | (8,056,740) | (14,031,505) | -42.6% | | Net loss | (8,365,980) | (11,235,246) | -25.5% | | Net loss per share | (0.18) | (0.36) | -50.0% | H1 Financial Performance (Six Months Ended June 30) | Metric | 2025 ($) | 2024 ($) | YoY Change | | :--- | :--- | :--- | :--- | | Revenues, net | 13,832,489 | 9,451,117 | +46.4% | | Operating loss | (19,746,078) | (28,939,456) | -31.8% | | Net loss | (12,813,325) | (23,812,077) | -46.2% | | Net loss per share | (0.29) | (0.80) | -63.8% | [Condensed Consolidated Statements of Cash Flows](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) H1 2025 saw reduced cash used in operations, but a significant decrease in financing cash Cash Flow Summary (Six Months Ended June 30) | Activity | 2025 ($) | 2024 ($) | | :--- | :--- | :--- | | Net cash used in operating activities | (11,285,556) | (16,939,551) | | Net cash (used in) provided by investing activities | (4,698,645) | 52,272 | | Net cash provided by financing activities | 278,824 | 8,191,167 | | **Net decrease in cash** | **(15,705,377)** | **(8,696,112)** | [Notes to the Unaudited Condensed Consolidated Financial Statements](index=11&type=section&id=Notes%20to%20the%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) Details business segments, liquidity, a software acquisition, and a strategic pivot to FinTech - The company operates under three segments: Financial Technology (Credova BNPL and PSQ Payments), Marketplace (e-commerce and advertising), and Brands (EveryLife baby products)[20](index=20&type=chunk)[22](index=22&type=chunk)[24](index=24&type=chunk) - Despite a net loss of **$12.8 million** and negative operating cash flow of **$11.3 million** for the first six months of 2025, management believes existing cash of **$20.6 million** is sufficient to fund operations for the next year[27](index=27&type=chunk)[28](index=28&type=chunk) - In April 2025, the company acquired software assets and intellectual property for **$5.1 million** (paid in stock and potential earn-outs) to enhance its payment service offerings[62](index=62&type=chunk)[63](index=63&type=chunk) - Subsequent to the quarter, on August 12, 2025, the company announced a major strategic shift to accelerate FinTech growth by monetizing its Brands segment and pursuing a sale or strategic partnership for its Marketplace segment[126](index=126&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=31&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q2 2025 performance, strategic pivot to FinTech, and liquidity [Recent Developments and Strategic Updates](index=31&type=section&id=Recent%20Developments%20and%20Strategic%20Updates) Key board appointments and a strategic repositioning to prioritize the FinTech segment - Announced a strategic repositioning to focus on accelerating the growth of the FinTech segment[135](index=135&type=chunk) - As part of the new strategy, the company plans to monetize its Brands segment and pursue a sale or strategic partnership for its Marketplace segment[135](index=135&type=chunk) - Appointed Caitlin Long, a renowned Bitcoin and cryptocurrency finance expert, to its Board of Directors to support its Digital Asset Treasury Strategy[125](index=125&type=chunk)[133](index=133&type=chunk) [Results of Operations](index=36&type=section&id=Results%20of%20Operations) Q2 2025 revenues increased **18%** to **$7.1 million**, with operating loss reduced by **43%** Q2 2025 vs Q2 2024 Performance | Metric | Q2 2025 ($) | Q2 2024 ($) | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Revenues, net | 7,082,868 | 5,985,228 | 1,097,640 | 18% | | Total costs and expenses | 15,139,608 | 20,016,733 | (4,877,125) | (24)% | | Operating loss | (8,056,740) | (14,031,505) | 5,974,765 | (43)% | | Net loss | (8,365,980) | (11,235,246) | 2,869,266 | (26)% | - General and administrative expenses decreased by **$5.0 million (46%)** in Q2 2025, primarily due to a **$4.3 million** reduction in share-based compensation expense related to a modification for the former CFO[178](index=178&type=chunk) - Sales and marketing expenses decreased by **$2.3 million (45%)** in Q2 2025, driven by a **$1.2 million** reduction in advertising campaigns and a **$0.9 million** decrease in share-based compensation[180](index=180&type=chunk) [Key Business Metrics](index=35&type=section&id=Key%20Business%20Metrics) FinTech credit GMV declined **19%**, while PSQ Payments generated **$68.2 million** in Q2 2025 Financial Technology Segment GMV (Three Months Ended June 30) | Metric | 2025 ($) | 2024 ($) | % Change | | :--- | :--- | :--- | :--- | | GMV - Credit | 10,713,373 | 13,277,530 | (19)% | | GMV - PSQ Payments | 68,171,847 | 0 | 100% | - The decline in GMV-Credit was driven by a slowdown in the firearm retail industry and the company's focus on disciplined underwriting, with U.S. firearm sales falling for the fourth consecutive year in 2024[163](index=163&type=chunk) [Liquidity and Capital Resources](index=40&type=section&id=Liquidity%20and%20Capital%20Resources) Cash decreased to **$20.6 million**, but management deems it sufficient for the next 12 months - The company had **$20.6 million** in cash and cash equivalents as of June 30, 2025[193](index=193&type=chunk) - Net cash used in operating activities was **$11.3 million** for the six months ended June 30, 2025[192](index=192&type=chunk) - Management believes existing cash and cash equivalents are sufficient to fund operations and capital needs for the next year[195](index=195&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=43&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) As a smaller reporting company, PSQ Holdings, Inc. is exempt from providing this information - The company is a smaller reporting company and is not required to provide information for this item[207](index=207&type=chunk) [Controls and Procedures](index=43&type=section&id=Item%204.%20Controls%20and%20Procedures) Disclosure controls were ineffective due to a material weakness, with remediation efforts underway - Management concluded that disclosure controls and procedures were not effective as of June 30, 2025, due to a material weakness in internal control over financial reporting[208](index=208&type=chunk) - Remediation efforts include enhancing review processes for complex transactions, providing continuing education, automating processes, and hiring additional staff[209](index=209&type=chunk) [PART II—OTHER INFORMATION](index=44&type=section&id=PART%20II%E2%80%94OTHER%20INFORMATION) This part covers legal proceedings, risk factors, and exhibits for the reporting period [Legal Proceedings](index=44&type=section&id=Item%201.%20Legal%20Proceedings) Credova is responding to CFPB inquiries regarding lease products, potentially leading to enforcement - Credova is responding to inquiries from the Consumer Financial Protection Bureau (CFPB) regarding its lease products, which could lead to an enforcement action[120](index=120&type=chunk) [Risk Factors](index=44&type=section&id=Item%201A.%20Risk%20Factors) No material changes to risk factors were reported since the prior Annual Report on Form 10-K - No material changes to risk factors were reported since the last Annual Report on Form 10-K[213](index=213&type=chunk) [Exhibits](index=45&type=section&id=Item%206.%20Exhibits) Lists exhibits filed, including corporate governance, material agreements, and certifications